Clin2
NCT06623084Possibly a fitNot yet recruiting

Gut, Platelets, and Liver in Fatty Liver Disease

Non-alcoholic Fatty Liver Disease (NAFLD)NASH - Nonalcoholic SteatohepatitisCirrhosisControl Condition

Part of Digestive system clinical trials.

This study looks at how the connection between the gut, platelets, and liver affects the progression of fatty liver disease. It may help researchers understand why some people's liver disease gets worse.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
132 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must be at least 18 years old.
  • You must have been diagnosed with nonalcoholic fatty liver disease (NAFLD) based on current medical guidelines.
  • You cannot have advanced cirrhosis with complications like fluid buildup or confusion.
  • You cannot have other liver diseases (e.g., from infections or immune problems), gut issues like celiac or inflammatory bowel disease, or prior gastrointestinal surgery.
  • You cannot have a condition that affects bleeding or clotting, or a current or past cancer.
  • You must avoid taking certain medications (NSAIDs, antibiotics, probiotics, or stomach acid drugs) for 2 months before joining and for the study duration.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04371042Recruiting
Study of liver disease and genes in people with fatty liver

This study collects information about metabolic and unexplained (cryptogenic) liver disease and looks at “omics” tests, which are lab tests that measure patterns in blood or tissue to learn what drives the disease. It may help researchers better understand fatty liver and related serious complications, like liver scarring and liver cancer.

Roma, Rome/lazio/italy
NCT04925362Not yet recruiting
French study of fat in the liver and related health outcomes

This study follows adults with nonalcohol-related fatty liver disease (NAFLD) to better understand the condition and what factors affect it. It may help researchers learn which patients are most at risk and how care can be improved in the future.

NCT07265544Recruiting
Liver disease study using advanced tissue analysis

This study uses advanced techniques to analyze liver tissue samples from people with various liver conditions. It aims to better understand how liver diseases develop and progress, which may help improve future treatments.

Guangzhou, Guangdong
NCT06727279Not yet recruiting
Plant protein foods for fatty liver disease

This trial tests if special foods made from plant proteins can help people with non-alcoholic fatty liver disease (NAFLD) by improving their blood fats. You'll eat these foods while researchers check how well you tolerate them and whether they help your liver.

NCT04141592Recruiting
Study immune and disease changes in fatty liver

This study looks at what drives non-alcoholic fatty liver disease and how it affects the body, including immune-related changes. You may be invited if you have confirmed fatty liver disease or, alternatively, if you are a healthy person with no liver disease.

London, Greater London
NCT04036357Recruiting
Study of liver fat disease with heart and metabolism problems

This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.

Rome

Hear when a new NASH - Nonalcoholic Steatohepatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.